STAAR Surgical Company
STAA
$29.29
-$1.92-6.15%
NASDAQ
| 04/03/2026 | 01/02/2026 | 09/26/2025 | 06/27/2025 | 03/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 93.52M | 57.80M | 94.73M | 44.32M | 42.59M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 93.52M | 57.80M | 94.73M | 44.32M | 42.59M |
| Cost of Revenue | 24.66M | 14.06M | 16.86M | 11.52M | 14.58M |
| Gross Profit | 68.86M | 43.74M | 77.88M | 32.80M | 28.01M |
| SG&A Expenses | 41.45M | 45.40M | 44.16M | 47.19M | 51.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 76.04M | 68.71M | 70.23M | 68.98M | 77.27M |
| Operating Income | 17.48M | -10.91M | 24.50M | -24.66M | -34.68M |
| Income Before Tax | 8.22M | -20.65M | 18.79M | -25.92M | -54.49M |
| Income Tax Expenses | 3.01M | -2.34M | 9.91M | -9.10M | -275.00K |
| Earnings from Continuing Operations | 5.21M | -18.31M | 8.88M | -16.81M | -54.21M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.21M | -18.31M | 8.88M | -16.81M | -54.21M |
| EBIT | 17.48M | -10.91M | 24.50M | -24.66M | -34.68M |
| EBITDA | 19.59M | -8.90M | 26.50M | -22.68M | -32.34M |
| EPS Basic | 0.10 | -0.37 | 0.18 | -0.34 | -1.10 |
| Normalized Basic EPS | 0.22 | -0.11 | 0.31 | -0.26 | -0.40 |
| EPS Diluted | 0.10 | -0.37 | 0.18 | -0.34 | -1.10 |
| Normalized Diluted EPS | 0.22 | -0.11 | 0.31 | -0.26 | -0.40 |
| Average Basic Shares Outstanding | 49.91M | 49.76M | 49.63M | 49.52M | 49.34M |
| Average Diluted Shares Outstanding | 50.90M | 49.76M | 50.55M | 49.52M | 49.34M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |